Skip contents

Xendo Drug Development, a leading position in (LC-)ICP-MS bioanalysis for over 7 years

Xendo Drug Development, a leading position in (LC-)ICP-MS bioanalysis for over 7 years

Already for 7 years Xendo serves its bioanalytical customers with state-of-the-art ICP-MS technology and services. In this era we have developed numerous assays with a wide range of sample preparation techniques for a versatile range of body fluids and tissues. Our technological expertise and scientific approach are recognized by a vast group of customers.

A broad range of preclinical and clinical studies have been supported in these years, which includes pharmacokinetic studies, imaging studies, mass balance studies, metabolite profiling studies and pharmacodynamic studies (biomarkers) in different therapeutic areas (oncology, CNS, haematology, metabolism).

Most recent developments in the bioanalytical arena that we work on with (LC-)ICP-MS are the application of Dried Blood Spot sampling and quantification of (therapeutic) proteins, for which the technique is perfectly shaped.

In order to better inform you about our capabilities, we have recently updated our brochures for the application of ICP-MS, and we have attached them to this message as hyperlink, please click to open in the right-side corner.

We invite you to apply for a competitive bioanalytical bid for the support of your clinical development programmes with our ICP-MS and LC-ICP-MS technology.

For more information or contact for your Request for Proposal please don’t hesitate to contact me by telephone +31 610011810 or e-mail jelle.hempenius@xendo.com.